Reuters Health Report

Click to View in Browser 02/14/2014 FDA rejects wider use of Xarelto drug NEW YORK (Reuters) - U.S. health regulators have declined to approve proposed wider uses of Bayer AG and Johnson & Johnson's lucrative blood clot preventer Xarelto, the drugmakers said on Friday. Aveo, Astellas end pact to develop cancer drug tivozanib (Reuters) - Aveo Oncology and Astellas Pharma Inc said they would end an agreement to develop Aveo's lead experimental drug that has seen a string of failures in multiple cancer indications. Plain cigarette packs spur quitline calls: study NEW YORK (Reuters Health) - Drab olive cigarette packs bearing a prominent quit-smoking helpline number, introduced more than a year ago in Australia, had a sizeable and sustained effect on interest in quitting, researchers say. More Obamacare insurers in Louisiana reject AIDS patients NEW YORK (Reuters) - The only three insurance companies in Louisiana that sell healthcare policies under President Barack Obama's healthcare law throughout the state are rejecting payments from a federal program intended to help low-income HIV patients, advocacy groups said on Thursday. FDA denies approval to wider use of J&J's blood clot preventer (Reuters) - The U.S. Food and Drug Administration denied an approval to a wider use of Johnson & Johnson's heart drug Xarelto. California lawmaker wants warning labels on sugary drinks SACRAMENTO, California (Reuters) - Sodas and most other sugar-sweetened drinks sold in California would be required to carry warning labels for obesity, diabetes and tooth decay under a bill introduced in Sacramento on Thursday and backed by several public health advocacy groups. Are recommendations from remote dermatologists reliable? NEW YORK (Reuters Health) - Offsite doctors may be able to reliably evaluate hospitalized patients with possible skin conditions based on photographs and general health information, says a new study. Belgium extends "right-to-die" to terminally ill children BRUSSELS (Reuters) - Belgium became the first country to allow euthanasia for terminally ill children of any age on Thursday when its lower house of parliament passed new "right-to-die" legislation by a large majority. Physical activity levels low among 'healthy' smokers NEW YORK (Reuters Health) - Smokers without signs of lung disease may be raising their chances of developing lung problems and other health issues by being couch potatoes, Brazilian researchers say. Boehringer facing more than 2,000 U.S. lawsuits over blood thinner FRANKFURT (Reuters) - German drugmaker Boehringer Ingelheim said on Thursday it is facing more than 2,000 lawsuits in the United States over claims its blockbuster drug Pradaxa, the first in a new class of stroke prevention pills, caused severe and fatal bleeding. Related Video Major pileup on Pennsylvania Turnpike New York, Washington airports nearly empty after huge snowstorm The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend